| MeSH term | MeSH ID | Detail |
|---|---|---|
| Metabolic Syndrome | D024821 | 44 associated lipids |
| Hyperuricemia | D033461 | 4 associated lipids |
| Jaundice, Obstructive | D041781 | 2 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Renal Insufficiency, Chronic | D051436 | 9 associated lipids |
| Mucositis | D052016 | 7 associated lipids |
| Acute Lung Injury | D055371 | 33 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
Platelet activating factor
Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
Cross Reference
Introduction
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Platelet activating factor?
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- J. Lipid Res. (5)
- Proc. Natl. Acad. Sci. U.S.A. (2)
- Am. J. Physiol. Gastrointest. Liver Physiol. (2)
- Others (26)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
PubChem Associated disorders and diseases
What pathways are associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Platelet activating factor?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Platelet activating factor?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Platelet activating factor?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Platelet activating factor?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Platelet activating factor?
Knock-out
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Platelet activating factor
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Cao YZ et al. | Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells. | 2001 | Antioxid. Redox Signal. | pmid:11813988 |
| Claing A et al. | Comparison of the contractile and calcium-increasing properties of platelet-activating factor and endothelin-1 in the rat mesenteric artery and vein. | 2002 | Br. J. Pharmacol. | pmid:11815379 |
| Tibiriçá E | Cardiovascular properties of yangambin, a lignan isolated from Brazilian plants. | 2001 | Cardiovasc Drug Rev | pmid:11830750 |
| Barabé F et al. | Cholesterol-modulating agents selectively inhibit calcium influx induced by chemoattractants in human neutrophils. | 2002 | J. Biol. Chem. | pmid:11839753 |
| Ottino P and Bazan HE | Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites. | 2001 | Curr. Eye Res. | pmid:11840344 |
| Breschi MC et al. | Protective effect of silymarin in antigen challenge- and histamine-induced bronchoconstriction in in vivo guinea-pigs. | 2002 | Eur. J. Pharmacol. | pmid:11864645 |
| Küçükhüseyin C et al. | Renovascular actions of adenosine in the isolated perfused rat kidney: possible underlying mechanisms. | 2001 | J Basic Clin Physiol Pharmacol | pmid:11868905 |
| Tanaka Y et al. | Anti-CD44 monoclonal antibody (IM7) induces murine systemic shock mediated by platelet activating factor. | 2002 | J. Autoimmun. | pmid:11869042 |
| Mio T et al. | Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels. | 2002 | J. Lab. Clin. Med. | pmid:11873241 |
| Klein A et al. | Platelet-activating factor drives eotaxin production in an allergic pleurisy in mice. | 2002 | Br. J. Pharmacol. | pmid:11877329 |
| Teruel MN and Meyer T | Parallel single-cell monitoring of receptor-triggered membrane translocation of a calcium-sensing protein module. | 2002 | Science | pmid:11884760 |
| Bulger EM et al. | The macrophage response to endotoxin requires platelet activating factor. | 2002 | Shock | pmid:11900334 |
| Mitsuoka H et al. | Protease inhibition in the intestinal lumen: attenuation of systemic inflammation and early indicators of multiple organ failure in shock. | 2002 | Shock | pmid:11900339 |
| Kondratskaya EL et al. | BN52021, a platelet activating factor antagonist, is a selective blocker of glycine-gated chloride channel. | 2002 | Neurochem. Int. | pmid:11900860 |
| Matorras R and Pijoan JI | The improvement in pregnancy rates with platelet-activating factor in intrauterine insemination was not demonstrated. | 2002 | Am. J. Obstet. Gynecol. | pmid:11904634 |
| McClenahan DJ et al. | In vitro evaluation of the role of platelet-activating factor and interleukin-8 in Mannheimia haemolytica-induced bovine pulmonary endothelial cell injury. | 2002 | Am. J. Vet. Res. | pmid:11911574 |
| Schwartzkopff F et al. | The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor. | 2002 | J. Interferon Cytokine Res. | pmid:11911809 |
| Royal SJ et al. | Laminar disorganisation of mitral cells in the olfactory bulb does not affect topographic targeting of primary olfactory axons. | 2002 | Brain Res. | pmid:11911856 |
| Ko HM et al. | Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis. | 2002 | Cancer Res. | pmid:11912159 |
| Ishiguro K et al. | Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. | 2002 | Planta Med. | pmid:11914965 |
| Hu G et al. | Isoflurane inhibits neutrophil-endothelium interactions in the coronary circulation: lack of a role for adenosine triphosphate-sensitive potassium channels. | 2002 | Anesth. Analg. | pmid:11916783 |
| Ozgün H et al. | Lexipafant inhibits postsurgical adhesion formation. | 2002 | J. Surg. Res. | pmid:11922727 |
| Cellai C et al. | Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. | 2002 | FASEB J. | pmid:11923217 |
| Hostettler ME and Carlson SL | PAF antagonist treatment reduces pro-inflammatory cytokine mRNA after spinal cord injury. | 2002 | Neuroreport | pmid:11924887 |
| Barletta E et al. | Platelet activating factor inhibits the expression of matrix metalloproteinases and affects invasiveness and differentiation in a system of human neuroblastoma clones. | 2002 | Biol. Chem. | pmid:11928813 |
| Larrucea S et al. | Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin alphaIIbbeta3) and the platelet-activating factor: dissociation between adhesion and aggregation. | 2002 | Blood | pmid:11929771 |
| Ahamed J and Ali H | Distinct roles of receptor phosphorylation, G protein usage, and mitogen-activated protein kinase activation on platelet activating factor-induced leukotriene C(4) generation and chemokine production. | 2002 | J. Biol. Chem. | pmid:11934880 |
| Silva AR et al. | Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. | 2002 | J. Immunol. | pmid:11937571 |
| Tachibana A et al. | Respiratory syncytial virus enhances the expression of CD11b molecules and the generation of superoxide anion by human eosinophils primed with platelet-activating factor. | 2002 | Intervirology | pmid:11937770 |
| Kingston JK et al. | Measurement of the activation of equine platelets by use of fluorescent-labeled annexin V, anti-human fibrinogen antibody, and anti-human thrombospondin antibody. | 2002 | Am. J. Vet. Res. | pmid:11939312 |
| Deo DD et al. | Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. | 2002 | J. Biol. Chem. | pmid:11940567 |
| Strait RT et al. | Pathways of anaphylaxis in the mouse. | 2002 | J. Allergy Clin. Immunol. | pmid:11941316 |
| Xu N et al. | Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells. | 2002 | Biochem. Biophys. Res. Commun. | pmid:11944906 |
| Roudebush WE et al. | Embryonic platelet-activating factor: temporal expression of the ligand and receptor. | 2002 | J. Assist. Reprod. Genet. | pmid:11958508 |
| Calcerrada MC et al. | PAF-stimulated protein tyrosine phosphorylation in hippocampus: involvement of NO synthase. | 2002 | Neurochem. Res. | pmid:11958533 |
| Fragopoulou E et al. | Biologically active lipids with antiatherogenic properties from white wine and must. | 2002 | J. Agric. Food Chem. | pmid:11958642 |
| Lloberas N et al. | The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. | 2002 | Transplant. Proc. | pmid:11959179 |
| Castellvi J et al. | Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. | 2002 | Transplant. Proc. | pmid:11959181 |
| Bernatchez PN et al. | Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1. | 2002 | J. Cell. Biochem. | pmid:11968003 |
| Hostettler ME et al. | Platelet-activating factor induces cell death in cultured astrocytes and oligodendrocytes: involvement of caspase-3. | 2002 | Glia | pmid:11968060 |
| Boisfer E et al. | Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. | 2002 | J. Lipid Res. | pmid:11971944 |
| Steel HC and Anderson R | Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. | 2002 | Br. J. Pharmacol. | pmid:11976271 |
| McKay CJ | Recent developments in the management of acute pancreatitis. | 2002 | Dig Surg | pmid:11979001 |
| Roudebush WE et al. | Embryonic platelet-activating factor: an indicator of embryo viability. | 2002 | Hum. Reprod. | pmid:11980756 |
| de Souza LJ et al. | Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis. | 2001 Jul-Aug | J. Gastrointest. Surg. | pmid:11985976 |
| Jerkić M et al. | The mechanism of increased renal susceptibility to toxic substances in the elderly. Part I. The role of increased vasoconstriction. | 2001 | Int Urol Nephrol | pmid:11989542 |
| Kolaczkowska E et al. | Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. | 2002 | Inflammation | pmid:11989789 |
| Wang LS et al. | Effects of platelet activating factor, butyrate and interleukin-6 on cyclooxygenase-2 expression in human esophageal cancer cells. | 2002 | Scand. J. Gastroenterol. | pmid:11989839 |
| Börjesson A et al. | Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats. | 2002 | Dig Liver Dis | pmid:11990391 |
| Varon D and Brill A | Platelets cross-talk with tumor cells. | 2001 | Haemostasis | pmid:11990484 |